NEWS
The Clinical Research of Mistent® Coronary Drug Eluting Stent System
一、Stent Design The biodegradable coating (PLGA polymer combined with sirolimus crystals) was realized based on supercritical fluid technology, which gave birth to the Mistent® coronary
PAIRS 2025 | Expanding Horizons, Connecting Globally
We had a fantastic time at PAIRS 2025, held from April 9–12 at the Dubai World Trade Centre! As a company committed to innovation in
Exciting News | Seledora® Coronary Scoring Balloon Catheter Approved!
On March 14, 2025, Seledora® Coronary Scoring Balloon Catheter, developed by Mixin Medtech(Suzhou) Co., Ltd., a subsidiary of Kossel Medtech (Suzhou) Co., Ltd., received approval
Good news! Octoparms® Ⅱ Vena Cava Filter Obtained NMPA Certificate！
On March 14, 2025, the Octoparms® II vena cava filter independently developed by Kossel Medtech (Suzhou) Co., Ltd. was approved by the National Drug Administration
An Analysis of the “Long-lasting Efficacy” of the MiStent Stent
The MiStent coronary drug-eluting stent, an important overseas transformation project of Kossel Medtech has officially entered the Chinese market with two major advantages of “rapid
Mistent® Fast Healing” in Stent Analysis
Mistent® coronary drug-eluting stent system, as an important overseas transformation project of Kossel Medtech, has officially launched in the Chinese market with two advantages of